Perrigo Company plc (NYSE:PRGO) Shares Purchased by Quantinno Capital Management LP

Quantinno Capital Management LP boosted its position in Perrigo Company plc (NYSE:PRGO) by 687.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 155,033 shares of the company’s stock after purchasing an additional 135,338 shares during the quarter. Quantinno Capital Management LP owned about 0.11% of Perrigo worth $3,986,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in PRGO. Barclays PLC raised its position in shares of Perrigo by 44.8% in the third quarter. Barclays PLC now owns 120,502 shares of the company’s stock valued at $3,160,000 after buying an additional 37,268 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in Perrigo by 10.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 304,948 shares of the company’s stock valued at $7,840,000 after acquiring an additional 28,843 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Perrigo in the 4th quarter valued at about $691,000. Janney Montgomery Scott LLC lifted its stake in Perrigo by 39.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 90,624 shares of the company’s stock worth $2,330,000 after purchasing an additional 25,472 shares in the last quarter. Finally, Sound Income Strategies LLC boosted its holdings in shares of Perrigo by 28.6% during the 4th quarter. Sound Income Strategies LLC now owns 482,811 shares of the company’s stock worth $12,413,000 after purchasing an additional 107,427 shares during the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.

Perrigo Trading Up 2.8%

Shares of PRGO opened at $27.03 on Monday. Perrigo Company plc has a 12-month low of $23.14 and a 12-month high of $30.93. The firm has a market capitalization of $3.72 billion, a P/E ratio of -23.10 and a beta of 0.45. The firm has a 50-day moving average price of $26.25 and a 200 day moving average price of $26.15. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO) last posted its earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.04. The company had revenue of $1.04 billion for the quarter, compared to analyst estimates of $1.09 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. Perrigo’s revenue was down 3.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.29 EPS. Sell-side analysts forecast that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, May 30th. This represents a $1.16 annualized dividend and a yield of 4.29%. Perrigo’s dividend payout ratio (DPR) is -88.55%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com cut Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Perrigo presently has a consensus rating of “Hold” and a consensus price target of $33.00.

Insider Buying and Selling at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total transaction of $214,032.00. Following the completion of the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. This trade represents a 18.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.70% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.